Onsite Women's Health

What Onsite Women's Health does

Onsite Women's Health is a Nashville, Tennessee-based private healthcare services company that partners with OB/GYN and primary care physician practices to deliver turnkey in-office breast health and imaging services. Founded in 2008 and operating across 28 states with 175+ locations and a team of more than 600 employees, the company supplies 3D tomosynthesis mammography equipment, AI-integrated cancer detection software, ARRT-registered mammography technologists, and 100% board-certified breast-specialized radiologists to its 200+ practice partners without requiring any upfront capital outlay from the practices. Onsite performs more than 425,000 screening mammograms annually and projects approximately 600,000 breast exams in 2026.

The company's core technology stack combines state-of-the-art 3D mammography hardware with three integrated AI tools: Therapixel's MammoScreen for cancer detection, CureMetrix's cmAngio for cardiovascular risk assessment via Breast Arterial Calcification identification, and Volpara Analytics for image quality scoring. The proprietary PINk Platform (Patient Information Network) integrates with partner EHRs, tracks patient compliance with screening schedules, and provides population health metrics and patient CRM. Supporting services include diagnostic mammography, screening whole-breast ultrasound (ABUS/HHUS), OB-GYN ultrasound, and DEXA bone density, forming a comprehensive women's imaging portfolio.

Onsite operates a sales-led, B2B managed-services model in which it owns the equipment, manages staffing and compliance (ACR accreditation, FDA MQSA certification), and handles split-billing for diagnostic services. Practices retain a revenue stream from in-office imaging without operational burden. Distribution is exclusively through direct practice partnerships, supported by a dedicated Business Development team and Regional Directors conducting free profit projections and white-glove implementations. Recent strategic moves include the January 2025 acquisition of The Katherine M. Cyran M.D. Breast Center, multi-vendor AI partnership buildout (2023–2025), and $21 million of growth investment allocated in 2024.

Name

Onsite Women's Health

Legal name

Onsite Women's Health

Website

https://onsitewomenshealth.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

251–500 employees

Short description

Onsite Women's Health provides turnkey in-office breast health and imaging services, including 3D mammography with integrated AI, to 200+ OB/GYN and primary care practice partners across 28 states without requiring upfront capital from the practices.

Ownership category

akta.pro rank

Product category

Breast Health Imaging Services

NAICS

Diagnostic Imaging Centers (621512)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Breast Imaging Centers (Mammography/Tomosynthesis) (HLAFAKAD)

akta.pro secondary industry

Mammography & Breast Imaging Systems (HLAHABAF)

Keywords

• In-office mammography services
• Breast health imaging
• AI mammography screening
• Women's health diagnostics
• Physician practice partnerships

Headquarters

HQ city

Franklin

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

1. In-Office Breast Health Service Partnership: Onsite Women’s Health provides comprehensive in-office breast health and imaging services to physician practices. Onsite manages the complete service line including equipment provision, technologist staffing, radiologist interpretation, compliance oversight, and marketing support. The company generates revenue by enabling partner practices to offer mammography and related services to their patients, with practices benefiting from an additional revenue stream. Onsite handles all billing coordination, including split-billing for diagnostic services (technical component + professional component).

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Core offering

Onsite Women's Health provides turnkey, in-office breast health and imaging services to OB/GYN and primary care physician practices, including 3D screening mammography with integrated AI detection software, screening whole-breast ultrasound, diagnostic mammography and ultrasound, OB-GYN ultrasound, bone density (DEXA) scanning, and the AI-powered Mammo with Heart cardiovascular risk assessment program. The company provides all equipment, ARRT-registered mammography technologists, breast-specialized radiologists, ACR accreditation oversight, FDA compliance, and proprietary PINk Platform EHR integration.

Product overview

Onsite Women's Health offers a unified platform of in-office breast health and imaging services anchored by 3D screening mammography with integrated AI software. The core offering includes 3D Screening Mammography (with MammoScreen AI), Screening Whole-Breast Ultrasound (ABUS/HHUS), Diagnostic Mammography + Ultrasound, OB-GYN Ultrasound, and Bone Density (DEXA). The Mammo with Heart add-on module extends mammography to assess cardiovascular risk via BAC detection. Supporting infrastructure includes the PINk Software (Patient Information Network) proprietary platform for EHR integration, patient tracking, and marketing CRM. Together, these services enable physician practices to deliver comprehensive breast and women's health imaging without patients leaving the practice.

Differentiator

Problem solved

Functional benefit

Brands

• PINk Platform: Proprietary software platform also known as Patient Information Network that integrates with EHR, tracks patient compliance, and enables customized marketing materials with patient CRM and population metrics.
• Mammo with heart
• The Katherine M. Cyran M.D. Breast Center

Products and services

• 3D Screening Mammography with Integrated AI Software 3D screening mammography (tomosynthesis) for breast cancer detection in asymptomatic women. Each mammogram includes MammoScreen AI software providing AI-driven insights to support earlier and more accurate detection. Delivered in-office at OB/GYN and primary care physician partner practices.
• Screening Whole-Breast Ultrasound Supplemental breast ultrasound screening using Automated Whole-Breast Ultrasound (ABUS) and Handheld Whole-Breast Ultrasound (HHUS) for women with dense breast tissue. Provides real-time imaging to evaluate areas of concern and determine whether findings are fluid-filled, fatty or solid masses.
• Diagnostic Mammography + Diagnostic Ultrasound Comprehensive evaluation of breast abnormalities offering diagnostic mammography and breast ultrasound together, providing continuity of care, faster appointment availability, and stronger patient retention for partner practices.
• Mammo with Heart AI-enhanced screening program using CureMetrix cmAngio software to identify Breast Arterial Calcifications (BAC) during routine mammograms, providing cardiovascular risk assessment without additional imaging, appointments, or radiation exposure. Offered as an optional service not covered by insurance; patients who opt in pay out of pocket.
• OB-GYN Ultrasound Comprehensive in-office OB-GYN ultrasound imaging solutions including pelvic transvaginal, transabdominal, first trimester, OB Limited, Color Doppler, Biophysical Profile, Saline Infused Sonohysterogram (SIS), Nuchal Translucency, and Fetal Doppler services for OB/GYN partner practices.
• Bone Density (DEXA) Bone density screening services offered alongside breast screening to aid in early detection of osteoporosis and bone loss, improving patient compliance and providing convenient access to both screenings in one visit at partner practices.
• PINk Software (Patient Information Network) Proprietary software platform that integrates with partner practice EHR systems, tracks patients for exam compliance, and enables customized marketing materials with Patient CRM and population health metrics.

Quantifiable outcome

• 85% patient compliance rate for mammography vs. 50% national average (Academic Radiology)
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability8 records

Feature5 records

Partnerships

Five partnerships are on record, tiered core and key.

• TherapixelcoreTechnology or Integration · 1 April 2025Onsite Women’s Health partnered with Therapixel to deploy MammoScreen AI software across its national provider network. MammoScreen provides AI-powered mammography screening that serves as a second opinion without a second appointment, increasing radiologist performance in detecting cancer earlier while reducing unnecessary callbacks and procedures.
• CureMetrixcoreTechnology or Integration · 24 July 2024Onsite Women’s Health partners with CureMetrix to power the Mammo with Heart program, which uses cmAngio AI software to identify Breast Arterial Calcifications (BAC) on screening mammograms. This enables cardiovascular risk assessment at the point of breast cancer screening, adding clinical value without additional appointments, time, or radiation exposure for patients.
• Medicom Technologies Inc.keyTechnology or Integration · 1 November 2023Onsite Women’s Health established a strategic partnership with Medicom Technologies Inc. to elevate the patient and clinician journey through advancements in medical image exchange. The partnership creates a platform for secure and efficient sharing and interpretation of medical images across the Onsite network.
• Myriad GeneticskeyStrategic or Co-development Partner · 1 August 2023Onsite Women’s Health partners with Myriad Genetics to bring hereditary breast cancer risk assessment resources, including MyRisk with RiskScore, into Onsite provider practices. This enables younger patients to be screened for breast cancer risk more readily, with women identified as high-risk advised on guidelines for screening at younger ages.
• Volpara Analytics (Volpara Health)keyTechnology or Integration · 1 February 2023Onsite Women’s Health and Volpara Health announced a national partnership to improve and sustain quality through consistent, fair, and unbiased assessment of mammogram positioning and overall image quality. Volpara Analytics AI software reviews each Onsite mammogram image for appropriate positioning, compression, and radiation dose.

Scale indicators9 records

Recent moves8 records

Expansion highlights7 records

Others

• Therapixel: Therapixel is a French AI medical imaging company whose MammoScreen AI is deployed across Onsite's national provider network. It is a thematic/ecosystem participant — a technology supplier whose products directly power Onsite's breast cancer detection capability.

Broad incumbents

• HCA Healthcare: HCA Healthcare is the largest hospital operator in the U.S. and operates extensive outpatient imaging services, including breast imaging. Its integrated hospital-and-physician strategy and capital scale represent a significant competitive threat to independent breast imaging providers like Onsite.
• RadNet: RadNet is a leading national outpatient imaging network operating hundreds of centers across the U.S., including mammography and breast imaging. It is a broad incumbent whose scale, payer contracts, and capital base represent the primary competitive threat to Onsite's in-office partnership model.
• Akumin: Akumin is a national provider of outpatient diagnostic imaging services, including mammography, with both fixed-site centers and mobile imaging. Its full-modality imaging portfolio makes it a broad incumbent comparable to Onsite's specialized breast health offering.

Emerging players

• CureMetrix: CureMetrix is an AI imaging company whose cmAngio technology powers Onsite's Mammo with Heart program. It is an emerging player in the breast-imaging AI space, and a strategic technology partner that could become a direct channel competitor if it expands its own clinical service footprint.
• Volpara Health: Volpara Health provides AI-driven breast imaging quality and risk analytics software and is a national partner of Onsite. It is an emerging software player in the breast health ecosystem whose technology is embedded in Onsite's clinical workflow.
• Myriad Genetics: Myriad Genetics provides hereditary cancer risk testing (MyRisk with RiskScore) and partners with Onsite to bring risk assessment into Onsite practices. It is an emerging player adjacent to the breast health workflow, with potential to expand into broader women's health risk assessment.

Direct peers

• Solis Mammography: Solis Mammography is the largest independent provider of mammography and breast health services in the U.S., operating dedicated breast imaging centers. It is the closest direct competitor to Onsite's breast-focused imaging model, differentiating through subspecialist radiologists and a similar patient-experience focus.
• US Radiology Specialists: US Radiology Specialists is a national physician-led radiology practice that partners with hospitals, health systems, and outpatient sites to deliver imaging services. Its outsourced imaging platform is directly comparable to Onsite's outsourced breast-imaging service line for physician practices.
• SimonMed Imaging: SimonMed Imaging is one of the largest outpatient imaging providers in the U.S., offering mammography, MRI, CT, and other modalities. Its national scale and direct-to-patient offering make it a direct comparable for Onsite's diagnostic and screening breast imaging services.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/OnsiteWomens
• Facebookfacebook.com/osmammo
• LinkedInlinkedin.com/company/onsitewomenshealth

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Onsite Women's Health